Full-Time

Senior Machine Learning Engineer

Posted on 10/18/2023

Absci

Absci

51-200 employees

Biotech solutions for protein expression and purification

Biotechnology
Healthcare

Senior

Remote in USA + 1 more

More locations: Vancouver, WA, USA

The position is remote within the United States, Canada, Serbia, or Switzerland, with hybrid work available in Vancouver, WA;, New York City; or Belgrade Serbia. Absci is a global company with headquarters in the Pacific Northwest US and an AI Research Lab in New York City.

Category
Applied Machine Learning
Deep Learning
Natural Language Processing (NLP)
AI & Machine Learning
Required Skills
Python

You match the following Absci's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • 4-8+ years of experience designing and building production grade software solutions
  • 4+ years of experience working on ML/AI Systems
  • Proven Track record of creating an engineering project roadmaps and executing on it by delivering high impact work
  • Proven track record of fostering high performing teams and upleveling those around you by coaching and mentoring less experienced engineers on the team
  • Experience building ML/AI systems within the Python ecosystem in the cloud, on-premises, or hybrid
  • Excellent written and oral communication skills
  • Comfortable working in a fast-paced work environment with high autonomy and matching accountability
Responsibilities
  • Act as the technical lead and owner for specific problem spaces in AI workflows
  • Building ML/AI software systems using various tools
  • Work with interdisciplinary teams to build consensus and define achievable product roadmaps
  • Set and implement strategy to deliver on team's objectives and manage technical debt
  • Mentor and coach less experienced engineers on the team

AbSci focuses on improving protein expression and biomanufacturing in the biotech industry. Its main product is an advanced protein expression platform that uses a semi-oxidizing cytoplasm and a dual inducible promoter system, allowing for better control over protein production rates. This results in higher quality and more efficient drug manufacturing. A key feature of AbSci's offerings is SoluPure, a method that simplifies protein purification without chromatography, speeding up the production process and reducing costs. Unlike traditional methods that rely on mammalian expression systems, AbSci's technology can generate cell lines that produce active proteins in just three months. The company partners with pharmaceutical and biotech firms to provide these solutions, aiming to enhance drug discovery and manufacturing processes. AbSci's goal is to challenge conventional practices in the industry and create effective tools for producing biologics.

Company Stage

IPO

Total Funding

$221.7M

Headquarters

Vancouver, Washington

Founded

2011

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Absci's partnerships with AMD and Owkin enhance AI-driven drug discovery capabilities.
  • Generative AI collaborations with MSK and Twist Bioscience accelerate novel therapeutic development.
  • Increased adoption of AI and synthetic biology boosts Absci's innovative drug designs.

What critics are saying

  • Growing competition in AI-driven drug discovery may impact Absci's market share.
  • Dependence on partnerships could pose risks if collaborations don't yield results.
  • Rapid tech advancements could render Absci's current technologies obsolete.

What makes Absci unique

  • Absci uses AI and synthetic biology for novel protein-based drug discovery.
  • Their SoluPure method simplifies protein purification, reducing production time and costs.
  • Absci's high-throughput workflow generates active protein products in just three months.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Parental Leave

401(k) Retirement Plan

401(k) Company Match

Company Equity

Employee Stock Purchase Plan

INACTIVE